Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Periprosthetic Fracture Registry (PPFx)

NCT03378557 · tracked via the Priya Life Science Spain tracker
Phase
Observational
Started
2018-12-31
Last updated
2025-09-12

Condition(s) studied

Periprosthetic FracturesPeriprosthetic Fracture Around Prosthetic Joint Implant

Study summary

This registry supports international data collection and research on PPFx treatments after hip and knee arthroplasty.

A registry such as this ultimately aims to provide far-reaching benefits to society including reduced morbidity and mortality, improved patient safety, improved quality of care and medical decision-making, reduced medical spending, and advances in orthopaedic science.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age ≥18 years * Post-operative PPFx after total or hemi hip or total or unicondylar knee arthroplasty (including the acetabulum, femur, patella and proximal tibia) requiring * osteosynthesis alone or * component revision plus plate/nail osteosynthesis * Informed consent obtained, i.e.: * Ability of the patient or assigned representative to understand the content of the patient information / Informed Consent Form * Signed and dated EC / IRB approved written informed consent * Ability to attend post-operative follow up visits Exclusion Criteria: * Pregnancy or women planning to conceive within the study period * Prisoner

Primary outcome measure(s)

  • Classification of the fracture — Pre-operatively (Day -1)
    Classification of the fracture using the UCS and some parts of the AO/OTA fracture classification system.

Trial sites (13)

FacilityCityRegionStatus
University of Missouri Health Care Columbia Missouri Recruiting
Jersey City Medical Center RWJ Barnabas Health Jersey City New Jersey Recruiting
Saint Barnabas Medical Center Livingston Livingston New Jersey Recruiting
Vanderbilt University Medical Center Nashville Tennessee Recruiting
Universitaire Ziekenhuiven Leuven Leuven Belgium Recruiting
Hospital Santa Clara Bogotá Colombia Recruiting
Charité Universitätsmedizin Berlin Berlin Germany Recruiting
BG-Unfallklinik Ludwigshafen Ludwigshafen Germany Recruiting
Universitätsklinikum Münster Münster Germany Recruiting
Hospital Universitario Son Llàtzer Palma de Mallorca Spain Recruiting
Universitätsspital Basel Basel Switzerland Recruiting
Kantonspital Baselland Liestal Switzerland Terminated
Universitätsspital Zürich Zurich Switzerland Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03378557 on ClinicalTrials.gov ↗ ← All trials in Spain